Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) ROI

Lantheus Holdings, Inc. (LNTH) ROI

  • 2022-12-31: ROI 2.79%.
  • 2021-12-31: ROI -11.15%.
  • 2021-03-31: ROI -1.10%.
  • 2020-12-31: ROI -1.84%.

Complete source-backed roi history.

Available history
2017-12-31 to 2022-12-31
Data captured

Historical ROI

DateROI
2022-12-312.79%
2021-12-31-11.15%
2021-03-31-1.10%
2020-12-31-1.84%
2020-09-300.05%
2020-06-301.57%
2020-03-318.08%
2019-12-3110.26%

Annual ROI

DateROI
2022-12-312.79%
2021-12-31-11.15%
2020-12-31-1.84%
2019-12-3110.26%
2018-12-3112.01%
2017-12-3142.34%

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B